logo

Ovid Therapeutics Inc. (OVID)



Trade OVID now with
  Date
  Headline
3/3/2021 7:05:33 AM Takeda Gets Global Rights At Closing From Ovid For Soticlestat For Dravet Syndrome, Lennox-Gastaut Syndrome
5/30/2017 8:15:52 AM William Blair Starts Ovid Therapeutics Inc. (OVID) At Outperform